| ￥3300 | |
| Z05856-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 47.76 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 70-90 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
The purity of SR-BI/SCARB1, His, Human is greater than 90% as determined by SEC-HPLC. »
SR-BI/SCARB1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | The scavenger receptor class B member 1 (SR-B1 or Scarb1) is a glycosylated cell surface receptor for high density lipoproteins (HDL), oxidized low density lipoproteins (OxLDL), and phosphocholine-containing oxidized phospholipids (PC-OxPLs). Scarb1 is expressed in macrophages and has been shown to have both pro- and anti-atherogenic properties. |
| Synonyms | SRB1; SR-BI; SCARB1; CLA-1; CLA1; CD36; CD36L1; HDLQTL6 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
